DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20221375

Screening of mothers to detect Down syndrome: a practical approach in a resource limited setting

Shaji Thomas John, Kizhanipurath Gayathri

Abstract


Background: Advanced maternal age, history of abortion and/or bleeding in pregnancy are risk factors for the birth of a chromosomally abnormal child. This study was done to find out their relationship especially in Down syndrome (DS).

Methods: Retrospective observational study was done in children with DS and their mothers, from a major referral institution in India over a period of 20 years. The prevalence of abortion/bleeding in pregnancy with the age of mothers were analysed using statistical package for social sciences (SPSS) V20 software and compared in all the cytogenetic profiles.

Results: In mothers less than 35 years 21.8% had abortion, 8% had bleeding and 4.5% had both abortion and bleeding. In mothers more than 35 years 25% had abortion, 7.3% had bleeding and 4% had both abortion and bleeding. Thus 34.5% had abortion/bleeding in mothers less than 35 years and 36.8% in those above 35 years. 15.25% mothers were more than 35 years. When the individual cytogenetic pattern and the prevalence of abortion/bleeding were analysed in maternal age group less than 35 years; a higher prevalence was seen in the non-disjunction group (34.2%), followed by translocation (24%) and mosaic (21.42%). In maternal age group >35 years prevalence was high, though not statistically significant, in the mosaic group (66.67%) followed by non-disjunction (43%).

Conclusions: Mothers with a history of abortion/bleeding and those above 35 years constituted 44.7%. Ideally all pregnant women should be screened for chromosomal aneuploidies, but in resource limited countries screening should be done at least in the above noted high risk groups.


Keywords


Abortion, Bleeding, Maternal age, Down syndrome

Full Text:

PDF

References


Lee B. Down syndrome and other abnormalities of chromosome number. In: Kliegman RM, Blum NJ, Tasker RC, eds. Nelson textbook of Pediatrics. 21st ed. Elsevier. 2020;658-64.

Hassold TJ, Jacobs PA. Trisomy in man. Annu Rev Genet. 1984;18:69-97.

Petracchi F, Colaci DS, Igarzabal L, Gadow E. Cytogenetic analysis of first trimester pregnancy loss. Int J Gynaecol Obstet. 2009;104:243-4.

Wyatt PR, Owolabi T, Meier C, Huang T. Age-specific risk of fetal loss observed in a second trimester serum screening population. Am J Obstet Gynecol. 2005;192(1):240-6.

Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320(7251):1708-12.

Regan L, Braude PR, Trembath PL. Influence of past reproductive performance on risk of spontaneous abortion. BMJ. 1989;299(6698):541-5.

Soler A, Morales C, Mademont-Soler I, Margarit E, Borrell A, Borobio V et al. Overview of Chromosome Abnormalities in First Trimester Miscarriages: A Series of 1,011 Consecutive Chorionic Villi Sample Karyotypes. Cytogenet Genome Res. 2017;152(2):81-9.

Puri S, Morris J. Antenatal diagnosis: Giving the news. In: Newton RW, Puri S, Marder L, eds. Down syndrome Current perspectives. Mac Keith, 2015:13-22.

Alldred SK, Takwoingi Y, Guo B, Pennant M, Deeks JJ, Neilson JP et al. First trimester serum tests for Down's syndrome screening. Cochrane Database Syst Rev. 2015;2015(11):CD011975.

Wald NJ, Kennard A, Hackshaw AK. First trimester serum screening for Down's syndrome. Prenat Diagn. 1995;15(13):1227-40.

Huderer-Duric K, Skrablin S, Kuvacic I, Sonicki Z, Rubala D, Suchanek E. The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity. Eur J Obstet Gynecol Reprod Biol. 2000;88(1):49-55.

Alldred SK, Deeks JJ, Guo B, Neilson JP, Alfirevic Z. Second trimester serum tests for Down's Syndrome screening. Cochrane Database Syst Rev. 2012;(6):CD009925.

Wald NJ, Kennard A. Prenatal biochemical screening for Down's syndrome and neural tube defects. Curr Opin Obstet Gynecol. 1992;(2):302-7.

Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn. 2007;27(5):415-8.

Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62(4):768-75.

Rafi I, Chitti L. Cell free fetal DNA & non-invasive pre-natal diagnosis. British Journal of General Practice. 2009;59(562):e146-8.

Sparks AB, Struble CA, Wang ET, Song K, Oliphant A. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for Trisomy 21 and Trisomy 18. Am J Obstet Gynecol. 2012;206(4):319-9.

Yuan SM, Liao C, Li DZ, Huang JZ, Hu SY, Ke M et al. Chorionic villus cell culture and karyotype analysis in 1983 cases of spontaneous miscarriage. Zhonghua Fu Chan Ke Za Zhi. 2017;52(7):461-6.

Kajii T, Ferrier A, Niikawa N, Takahar H, Ohama K, Avirachan S. Anatomic and chromosomal anomalies in 639 spontaneous abortuses. Hum Genet. 1980;55:87-98.

Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol. 1987;94(5):387-402.